Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 20581689)

1.

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Tien PC, Choi AI, Zolopa AR, Benson C, Tracy R, Scherzer R, Bacchetti P, Shlipak M, Grunfeld C.

J Acquir Immune Defic Syndr. 2010 Nov;55(3):316-22. doi: 10.1097/QAI.0b013e3181e66216.

2.

Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.

Reingold J, Wanke C, Kotler D, Lewis C, Tracy R, Heymsfield S, Tien P, Bacchetti P, Scherzer R, Grunfeld C, Shlipak M.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):142-8. doi: 10.1097/QAI.0b013e3181685727.

3.

Association of low level viremia with inflammation and mortality in HIV-infected adults.

Eastburn A, Scherzer R, Zolopa AR, Benson C, Tracy R, Do T, Bacchetti P, Shlipak M, Grunfeld C, Tien PC.

PLoS One. 2011;6(11):e26320. doi: 10.1371/journal.pone.0026320. Epub 2011 Nov 2.

4.

Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

Cockerham L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, Grunfeld C, Shlipak M, Tien PC.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):102-6. doi: 10.1097/QAI.0b013e3181b79d22.

5.

Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study.

Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT.

Eur J Epidemiol. 2013 Jul;28(7):541-50. doi: 10.1007/s10654-013-9819-6. Epub 2013 Jul 3.

PMID:
23821244
6.
7.

Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.

Sanchez PL, Morinigo JL, Pabon P, Martin F, Piedra I, Palacios IF, Martin-Luengo C.

Heart. 2004 Mar;90(3):264-9.

8.

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, Ledergerber B, Lundgren J, Neuhaus J, Nixon D, Paton NI, Neaton JD; INSIGHT SMART Study Group.

PLoS Med. 2008 Oct 21;5(10):e203. doi: 10.1371/journal.pmed.0050203.

9.

Decreased limb muscle and increased central adiposity are associated with 5-year all-cause mortality in HIV infection.

Scherzer R, Heymsfield SB, Lee D, Powderly WG, Tien PC, Bacchetti P, Shlipak MG, Grunfeld C; Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM).

AIDS. 2011 Jul 17;25(11):1405-14. doi: 10.1097/QAD.0b013e32834884e6.

10.

Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.

Selim G, Stojceva-Taneva O, Zafirovska K, Sikole A, Gelev S, Dzekova P, Stefanovski K, Koloska V, Polenakovic M.

Prilozi. 2006 Jul;27(1):133-44.

PMID:
16985487
11.

C-reactive protein is a marker for human immunodeficiency virus disease progression.

Lau B, Sharrett AR, Kingsley LA, Post W, Palella FJ, Visscher B, Gange SJ.

Arch Intern Med. 2006 Jan 9;166(1):64-70.

PMID:
16401812
12.

Association of antiretroviral therapy with fibrinogen levels in HIV-infection.

Madden E, Lee G, Kotler DP, Wanke C, Lewis CE, Tracy R, Heymsfield S, Shlipak MG, Bacchetti P, Scherzer R, Grunfeld C.

AIDS. 2008 Mar 30;22(6):707-15. doi: 10.1097/QAD.0b013e3282f560d9.

13.

C-reactive protein independently predicts HIV-related outcomes among women and children in a resource-poor setting.

Drain PK, Kupka R, Msamanga GI, Urassa W, Mugusi F, Fawzi WW.

AIDS. 2007 Oct 1;21(15):2067-75.

14.

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.

Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG.

JAMA. 2013 Jun 12;309(22):2353-61. doi: 10.1001/jama.2013.5732.

PMID:
23757083
15.

Nutrition and inflammation serum biomarkers are associated with 12-week mortality among malnourished adults initiating antiretroviral therapy in Zambia.

Koethe JR, Blevins M, Nyirenda C, Kabagambe EK, Shepherd BE, Wester CW, Zulu I, Chiasera JM, Mulenga LB, Mwango A, Heimburger DC.

J Int AIDS Soc. 2011 Apr 10;14:19. doi: 10.1186/1758-2652-14-19.

16.

Role of C-reactive protein in HIV infection: a pilot study.

Chaudhary M, Kashyap B, Gautam H, Saini S, Bhalla P.

Viral Immunol. 2008 Jun;21(2):263-6. doi: 10.1089/vim.2007.0083.

PMID:
18570591
17.

Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.

Ledwaba L, Tavel JA, Khabo P, Maja P, Qin J, Sangweni P, Liu X, Follmann D, Metcalf JA, Orsega S, Baseler B, Neaton JD, Lane HC; Project Phidisa Biomarkers Team.

PLoS One. 2012;7(3):e24243. doi: 10.1371/journal.pone.0024243. Epub 2012 Mar 20.

18.

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, Mugerwa RD, Ellner JJ.

AIDS. 2000 Jun 16;14(9):1219-28.

19.

C-reactive protein is an independent predictor of mortality in women with HIV-1 infection.

Feldman JG, Goldwasser P, Holman S, DeHovitz J, Minkoff H.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):210-4.

PMID:
12571532
20.

Prevalence and factors associated with dry skin in HIV infection: the FRAM study.

Lee D, Benson CA, Lewis CE, Grunfeld C, Scherzer R.

AIDS. 2007 Oct 1;21(15):2051-7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk